• about axogen
    • management team
    • board of directors
    • careers
    • partners
    • esg report
    • code of ethics and conduct
    • patents
  • investors
  • news
  • contact
    • find a rep
    • international distributors
    • find referring surgeon
  • healthcare professionals
  • patients
COVID-19 Statement A letter from our CEO
Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • ESG Report
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2022

Jan 9, 2023

Axogen Announces Independent Publication of Comparative Nerve Gap Repair Meta-Analysis of 35 peer-reviewed studies of Allograft, Autograft, and Conduits

Jan 5, 2023

Axogen to Participate at J.P. Morgan 41st Annual Healthcare Conference

Jan 4, 2023

Axogen Patient to Ride the 2023 Donate Life Rose Parade® Float Supporting awareness of organ and tissue donation

Dec 19, 2022

Axogen, Inc Reports 2022 Third Quarter Financial Results

Nov 8, 2022

Axogen to Participate at Upcoming Investor Conferences

Nov 3, 2022

Axogen, Inc. announces the appointment of Adrian Tyndall, M.D. MPH, FACEP to its Board of Directors and the retirement of founding Director Mark Gold, M.D.

Oct 31, 2022

Axogen, Inc. to report third quarter 2022 financial results and host conference call on November 8, 2022

Oct 20, 2022

Axogen to Participate in the 77th Annual Meeting of the American Society for Surgery of the Hand

Sep 22, 2022

Axogen, Inc Reports 2022 Second Quarter Financial Results

Aug 3, 2022
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...29
Next

13631 Progress Blvd, Suite 400
Alachua, FL 32615

  • contact
  • careers
  • Privacy Policy
  • Terms of Use
  • Legal Notices
  • Instagram Logo
  • Twitter Logo
  • Linkedin Logo
  • Facebook Logo

© 2023 Axogen Corporation. The stylized "a" logo, Revolutionizing the Science of Nerve Repair and Avance Nerve Graft are trademarks of Axogen Corporation.

Top

You are now leaving axogeninc.com

Axogen is not responsible for content or policies on linked sites.